Function, a personalized health testing platform, has secured $450 million in growth financing from General Catalyst Partners. The company offers access to over 100 blood tests through a yearly subscription model.

This significant capital infusion is intended to accelerate Function's mission to make its platform accessible to millions more people. The funding underscores General Catalyst's strong belief in Function's innovative approach to health.

Pranav Singhvi, partner and co-head of CVF at General Catalyst, stated, "This financing reflects our belief that Function is one of the defining companies of our generation." He further highlighted Function's "entirely new approach to health" and its potential to reach a vast audience.

Function was launched in 2023, with Jonathan Swerdlin serving as co-founder and CEO.